Compare EVO & MVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVO | MVST |
|---|---|---|
| Founded | 1993 | 2006 |
| Country | Germany | United States |
| Employees | 4553 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 934.1M | 987.8M |
| IPO Year | N/A | N/A |
| Metric | EVO | MVST |
|---|---|---|
| Price | $3.00 | $1.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $7.00 | $6.00 |
| AVG Volume (30 Days) | 85.0K | ★ 4.7M |
| Earning Date | 04-08-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.37 | $24.55 |
| Revenue Next Year | $10.05 | $17.08 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.31 | $1.17 |
| 52 Week High | $4.48 | $7.12 |
| Indicator | EVO | MVST |
|---|---|---|
| Relative Strength Index (RSI) | 53.04 | 44.03 |
| Support Level | $2.88 | N/A |
| Resistance Level | $3.36 | $2.16 |
| Average True Range (ATR) | 0.09 | 0.15 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 54.34 | 29.71 |
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extends from core battery chemistry to battery packs.